BioSpace News Archive

Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced its financial results for the first quarter ended March 31, 2020.

Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of certain cancers and inflammatory diseases, announced its financial results for the first quarter ended March 31, 2020 and provided an update on recent corporate and clinical development highlights.

vTv Therapeutics Inc. (Nasdaq:VTVT) today reported financial results for the first quarter ended March 31, 2020, and provided an update on recent clinical achievements.

A world-renowned leader in infectious disease and transfusion medicine research, Vitalant Research Institute (VRI) is expanding plasma collections in San Francisco in the fight against COVID-19

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19, under an exceptional approval pathway

BetterLife Pharma Inc. announced that it has entered into an agreement to acquire worldwide rights to commercialize and sell AntiCovir, a potential COVID-19 treatment, from Altum Pharmaceuticals Inc. AntiCovir is an Interferon a2b based potential treatment that is proposed to be administered using a Metered Dose Inhaler or a nebulizer.

More than ever before, collaboration and efficiency are critical in scientific research as the world seeks solutions to the Coronavirus Pandemic. In recent weeks, pharma, financial and federal organizations made deliberate shifts, changing several facets of clinical trials to allow research to proceed at an unprecedented pace.

The general meeting adopted the income statement and balance sheet for the company and for the group in accordance with submitted accounting documents.

Groundbreaking platform combines novel laser wavelength with fully integrated tissue temperature monitoring and control systems to deliver a paradigm-shifting non-systemic solution for acne sufferers

Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the “Company”), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, announces that Pixee Medical, a France-based medical company, has received CE marking certification for Knee+, the first orthopedic navigation system using augmented reality smart glasses for total knee arthroplasty.